Delivery Order HHSN272201100021I-HHSN27200009

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $9,967,500.00 cost-plus-fixed-fee contract supports NIAID's Preclinical Development program, specifically the production of the MHRP GP145 Clade C trimer protein. This contract does not have a set-aside designation. ABL, a for-profit manufacturer of goods, has been...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of HIV-1gp120 protein in support of NIAID's preclinical development program. The contract, which does not have a set-aside designation, has a ceiling value of $4,240,924.91 and an ultimate...

This federal contract award, with a total ceiling value of $2,250,744.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization focused on HIV vaccine development. The purpose of the contract is to develop an optimized Phase 1 current Good Manufacturing Practice (cGMP) manufacturing process for lipid nanoparticle (LNP) fabrication that enables covalent coupling of an HIV-1 envelope...

This federal contract award is for NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENVELOPE TRIMER PROTEINS, with a ceiling value of $3,816,780.25. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods specializing in the development of vaccines, therapeutics, and diagnostics. The contract is a delivery order under the NIAID PRECLINICAL DEVELOPMENT SUPPORT - PERFORMANCE OF TOXICITY TESTING FOR HIV PROTEINS...

This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $17,241,407.00 task order supports good manufacturing practice (cGMP) manufacturing of the PGT121.414.LS monoclonal antibody (PGT121.414.LS mAb) drug substance, complete fill-finish of the drug substance into drug product, and...

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Ehime University, a non-profit organization, to provide wheat-germ cell-free protein production and purification services for malaria PHAP2 (9 mg) and HisGST (1 mg) proteins. The service will support malaria vaccine development and functions of multiple lab sections for the NIH. The $40,000.00 contract was awarded on...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...

This is a $9,545,732.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of cGMP native flexibly linked HIV-1 envelope protein to support NIAID's preclinical development efforts. This contract is not set aside and is part of a larger $24...

This federal contract award, valued at $1,469,410.09, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods and a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract is for NIAID...